ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$260,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Government bodies contacted 3

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025

Lobbying activity 2

Health Issues

HR 1262/ S 932 - Give Kids a Chance Act of 2025 HR 1509/ S 752 - Accelerating Kids' Access to Care Act & Give Kids a Chance Act 2025 Newborn Screening, including Appropriations

Medicare/Medicaid

Medicaid Value-Based Payments for Patients (MVP) Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.